Butterfly Network Execs to Present at TD Cowen’s Medical Devices Call
Event summary
- Butterfly Network (NYSE: BFLY) will participate in TD Cowen’s Medical Devices Emerging Growth Call Series on June 18, 2026.
- CEO Joseph DeVivo, CFO John Doherty, and SVP of Innovation David Horsley will lead the discussion.
- The event will be available as an audio-only webcast via Butterfly’s investor relations page.
- Butterfly Network focuses on Ultrasound-on-Chip™ technology and AI-driven medical imaging solutions.
The big picture
Butterfly Network’s participation in TD Cowen’s call underscores its strategic focus on expanding its Ultrasound-on-Chip™ technology and AI-driven solutions. The company aims to drive adoption in both medical and non-medical sectors, positioning itself as a leader in affordable, accessible ultrasound imaging. The call provides an opportunity to assess Butterfly’s market positioning and financial health amid broader industry trends in digital health innovation.
What we're watching
- Market Positioning
- How Butterfly Network will differentiate itself in the competitive medical imaging market.
- Technological Adoption
- The pace at which Butterfly’s Ultrasound-on-Chip™ technology gains traction in non-competitive healthcare markets.
- Financial Performance
- Whether Butterfly can sustain its growth trajectory amid increasing competition.